209 related articles for article (PubMed ID: 15380353)
1. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation.
Carroll PA; Brazeau E; Lagunoff M
Virology; 2004 Oct; 328(1):7-18. PubMed ID: 15380353
[TBL] [Abstract][Full Text] [Related]
2. Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Gutierrez KD; Morris VA; Wu D; Barcy S; Lagunoff M
J Virol; 2013 Jun; 87(12):6758-68. PubMed ID: 23552426
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.
Yogev O; Lagos D; Enver T; Boshoff C
PLoS Pathog; 2014 Sep; 10(9):e1004400. PubMed ID: 25255370
[TBL] [Abstract][Full Text] [Related]
4. Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells.
Morris VA; Punjabi AS; Lagunoff M
J Virol; 2008 Sep; 82(17):8771-9. PubMed ID: 18579585
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications.
Sivakumar R; Sharma-Walia N; Raghu H; Veettil MV; Sadagopan S; Bottero V; Varga L; Levine R; Chandran B
J Virol; 2008 Feb; 82(4):1759-76. PubMed ID: 18057235
[TBL] [Abstract][Full Text] [Related]
6. Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus.
Yoo J; Kang J; Lee HN; Aguilar B; Kafka D; Lee S; Choi I; Lee J; Ramu S; Haas J; Koh CJ; Hong YK
PLoS Pathog; 2010 Aug; 6(8):e1001046. PubMed ID: 20730087
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E
Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212
[TBL] [Abstract][Full Text] [Related]
8. Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus.
Poole LJ; Yu Y; Kim PS; Zheng QZ; Pevsner J; Hayward GS
J Virol; 2002 Apr; 76(7):3395-420. PubMed ID: 11884566
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.
Sharma-Walia N; Paul AG; Bottero V; Sadagopan S; Veettil MV; Kerur N; Chandran B
PLoS Pathog; 2010 Feb; 6(2):e1000777. PubMed ID: 20169190
[TBL] [Abstract][Full Text] [Related]
10. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Punjabi AS; Carroll PA; Chen L; Lagunoff M
J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
[TBL] [Abstract][Full Text] [Related]
11. Oroxylin A inhibits Kaposi's sarcoma-associated herpes virus (KSHV) vIL-6-mediated lymphatic reprogramming of vascular endothelial cells through modulating PPARγ/Prox1 axis.
Zhu X; Chen Y; Zhu W; Ji M; Xu J; Guo Y; Gao F; Gu W; Yang X; Zhang C
J Med Virol; 2019 Mar; 91(3):463-472. PubMed ID: 30318784
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of HDAC5 by Viral Interferon Regulatory Factor 3 Plays an Essential Role in Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphangiogenesis.
Lee HR; Li F; Choi UY; Yu HR; Aldrovandi GM; Feng P; Gao SJ; Hong YK; Jung JU
mBio; 2018 Jan; 9(1):. PubMed ID: 29339432
[TBL] [Abstract][Full Text] [Related]
13. The Lymphatic Cell Environment Promotes Kaposi Sarcoma Development by Prox1-Enhanced Productive Lytic Replication of Kaposi Sarcoma Herpes Virus.
Choi D; Park E; Kim KE; Jung E; Seong YJ; Zhao L; Madhavan S; Daghlian G; Lee HH; Daghlian PT; Daghlian S; Bui K; Koh CJ; Wong AK; Cho IT; Hong YK
Cancer Res; 2020 Aug; 80(15):3130-3144. PubMed ID: 32518204
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic Herpesvirus Engages Endothelial Transcription Factors SOX18 and PROX1 to Increase Viral Genome Copies and Virus Production.
Gramolelli S; Elbasani E; Tuohinto K; Nurminen V; Günther T; Kallinen RE; Kaijalainen SP; Diaz R; Grundhoff A; Haglund C; Ziegelbauer JM; Pellinen T; Bower M; Francois M; Ojala PM
Cancer Res; 2020 Aug; 80(15):3116-3129. PubMed ID: 32518203
[TBL] [Abstract][Full Text] [Related]
15. CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells.
Dai L; Trillo-Tinoco J; Chen Y; Bonstaff K; Del Valle L; Parsons C; Ochoa AC; Zabaleta J; Toole BP; Qin Z
Oncotarget; 2016 Jan; 7(4):3806-18. PubMed ID: 26675551
[TBL] [Abstract][Full Text] [Related]
16. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
[TBL] [Abstract][Full Text] [Related]
17. Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes.
DiMaio TA; Gutierrez KD; Lagunoff M
PLoS Pathog; 2011 Dec; 7(12):e1002424. PubMed ID: 22174684
[TBL] [Abstract][Full Text] [Related]
18. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.
Ojala PM; Schulz TF
Semin Cancer Biol; 2014 Jun; 26():69-77. PubMed ID: 24486643
[TBL] [Abstract][Full Text] [Related]
19. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.
Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS
J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969
[TBL] [Abstract][Full Text] [Related]
20. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
